Fahad Quhal Selected Research

Globulins

3/2022	Selection and evaluation of preoperative systemic inflammatory response biomarkers model prior to cytoreductive nephrectomy using a machine-learning approach.
1/2022	A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.
10/2021	Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer.
9/2021	Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer.
9/2021	Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy.
7/2021	Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma.
2/2021	Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma.
1/2021	Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.
8/2020	Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fahad Quhal Research Topics

Disease

29	Neoplasms (Cancer) 07/2022 - 01/2020
27	Carcinoma (Carcinomatosis) 08/2022 - 01/2020
22	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 05/2020
14	Urinary Bladder Neoplasms (Bladder Cancer) 11/2022 - 01/2021
12	Renal Cell Carcinoma (Grawitz Tumor) 07/2022 - 12/2020
7	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2020
6	Lymphatic Metastasis 08/2022 - 11/2021
6	Inflammation (Inflammations) 06/2022 - 10/2021
6	Non-Muscle Invasive Bladder Neoplasms 05/2022 - 01/2020
3	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 09/2021
2	Disease Progression 01/2022 - 01/2021
2	Febrile Neutropenia 01/2021 - 01/2021
2	Anemia 01/2021 - 01/2021
2	Fatigue 01/2021 - 01/2021
1	Urologic Neoplasms (Urological Cancer) 05/2022
1	Residual Neoplasm 04/2022
1	Kidney Calculi (Kidney Stone) 01/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2022
1	Injection Site Reaction 01/2022
1	Urinary Incontinence 01/2022
1	Erectile Dysfunction 04/2021
1	Diarrhea 01/2021
1	Infections 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Neutropenia 01/2021
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021
1	Dementia (Dementias) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 05/2022 - 08/2020
9	Immune Checkpoint InhibitorsIBA 07/2022 - 01/2021
9	GlobulinsIBA 03/2022 - 08/2020
7	AlbuminsIBA 03/2022 - 08/2020
6	Serum AlbuminIBA 10/2021 - 01/2021
5	AndrogensIBA 01/2022 - 05/2020
4	Androgen Receptors (Androgen Receptor)IBA 06/2022 - 11/2020
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2021
3	pembrolizumabIBA 01/2022 - 01/2021
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2021 - 05/2020
3	Alanine Transaminase (SGPT)IBA 06/2021 - 05/2020
2	AntigensIBA 01/2022 - 12/2020
2	C-Reactive ProteinIBA 01/2022 - 08/2020
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2021 - 01/2021
2	enzalutamideIBA 12/2020 - 11/2020
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2022
1	DNA (Deoxyribonucleic Acid)IBA 05/2022
1	PlatinumIBA 03/2022
1	Carboplatin (JM8)FDA LinkGeneric 03/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	NivolumabIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2022
1	atezolizumabIBA 01/2022
1	EndoglinIBA 01/2022
1	Solifenacin Succinate FDA Link 01/2022
1	relugolixIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	fesoterodine FDA Link 01/2022
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 01/2022
1	imidafenacinIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	oxybutynin (Tavor)FDA LinkGeneric 01/2022
1	N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	PlasminogenIBA 01/2021
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Axitinib (AG 013736)IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	taxaneIBA 01/2021
1	Sunitinib (Sutent)FDA Link 01/2021
1	ClaudinsIBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	avelumabIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021

Therapy/Procedure

24	Therapeutics 07/2022 - 05/2020
19	Cystectomy 08/2022 - 01/2020
13	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 05/2020
9	Drug Therapy (Chemotherapy) 05/2022 - 01/2020
7	Immunotherapy 05/2022 - 01/2021
7	Transurethral Resection of Bladder 04/2022 - 01/2021
6	Nephrectomy 07/2022 - 12/2020
6	Neoadjuvant Therapy 07/2022 - 01/2021
5	Radiotherapy 01/2022 - 05/2020
4	Castration 06/2022 - 11/2020
2	Adjuvant Chemotherapy 01/2022 - 06/2020
2	Nephroureterectomy 01/2022 - 07/2021
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 05/2020
1	Urinary Diversion (Ileal Conduit) 07/2022
1	Combination Drug Therapy (Combination Chemotherapy) 03/2022
1	Brachytherapy 01/2022
1	Radiofrequency Ablation 01/2022
1	Cryosurgery 01/2022
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 01/2022
1	Duration of Therapy 01/2021
1	Overlapping Surgery 01/2021